Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease

Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease

Abstract Chronic kidney disease (CKD) patients are at higher risk of severe COVID-19. Humoral and cellular immunity from prior infection or vaccination are important for protection, but the neutralizing antibody (nAb) response against SARS-CoV-2 variants is impaired. We investigated the variant-spec...

Full description

Bibliographic Details
Main Authors: Desmond Yat-Hin Yap, Carol Ho-Yan Fong, Xiaojuan Zhang, Jonathan Daniel Ip, Wan-Mui Chan, Allen Wing-Ho Chu, Lin-Lei Chen, Yan Zhao, Brian Pui-Chun Chan, Kristine Shik Luk, Vincent Chi-Chung Cheng, Tak-Mao Chan, Kelvin Kai-Wang To
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-47130-8

Internet

https://doi.org/10.1038/s41598-023-47130-8

Similar Items